© Globe Newswire
05.02.2026
FAGR
LISTED
EURONEXT
Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 5 February 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.02.2026
GN
LISTED
CPH
GN Annual Report 2025: Solid execution leading to market share gains, DKK 1.1 billion free cash flow, and a strong foundation for profitable growth in the years ahead
News Preview
2025 highlights...
Themefolio
Profiler
Peergroup
© BusinessWire
05.02.2026
MREO
LISTED
NASDAQ
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Mereo BioPharma Group plc Securities Class Action Lawsuit
News Preview
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Mereo BioPharma Group plc. (NASDAQ: MREO) American Depository Shares ("ADS") between June 5, 2023 and December 26, 2025. Mereo is a biopharmaceutical company focused on the development of therapeutics for rare diseases.
F...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© BusinessWire
05.02.2026
RARE
LISTED
NASDAQ
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Ultragenyx Pharmaceutical Inc. Securities Class Action Lawsuit
News Preview
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) common stock between August 3, 2023 and December 26, 2025. Ultragenyx is a biopharmaceutical company focused on rare and ultrarare genetic disorders.
For more information, sub...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
23.01.2026
© PR Newswire
05.02.2026
VNDA
LISTED
NASDAQ
Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026
News Preview
Conference Call and Webcast to FollowWASHINGTON, Feb. 4, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the fourth quarter and full year 2025 on Wednesday, February 11, 2026, after the market closes....
Themefolio
Profiler
Peergroup
© Newsfile
05.02.2026
MYTC
LISTED
CSE
MyndTec Inc. Completes Additional Tranche of Non-Brokered Private Placement
News Preview
Mississauga, Ontario--(Newsfile Corp. - February 4, 2026) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), a neurological treatment and rehabilitation medical technology company, is pleased to announce that it has closed an additional tranche of its non-brokered private placement previously announced on January 30, 2025 (the "Offering"). Th...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
VCYT
LISTED
NASDAQ
Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
News Preview
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, announced today that it will release financial results for the fourth quarter and full-year 2025 after the close of market on Wednesday, February 25, 2026. Company management will host a conference call and webcast to discuss financial results and provide a general business updat...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
PBYI
LISTED
NASDAQ
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on February 3, 2026, the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering 14,750 shares of Puma common stock to two new non-executive employees.
The awards were granted under Puma’s 2017 E...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
XRTX
LISTED
TSX
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
News Preview
CALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that further to its press release of October 17, 2025 a...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
TVTX
LISTED
NASDAQ
Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit
News Preview
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11, 2026, at 4:00 p.m. ET.
A live webcast will be accessible on the Investor page of Travere’s website at ir.travere.com/events-and-presentations, and a replay will be avail...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
PAHC
LISTED
NASDAQ
Phibro Animal Health Corporation Reports Second Quarter Results, Updates Financial Guidance
News Preview
Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2025, and its updated financial guidance for the year ending June 30, 2026.
Highlights for the three months ended December 31, 2025 (compared to the three months ended December 31, 2024):
Net...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
MCK
LISTED
NYSE
McKesson Corporation Reports Fiscal 2026 Third Quarter Results and Raises Full Year Adjusted EPS Guidance
News Preview
McKesson Corporation (NYSE: MCK) has released its fiscal 2026 third quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, Februa...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
04.02.2026
ALGN
LISTED
NASDAQ
Align Technology Announces Fourth Quarter and Fiscal 2025 Financial Results
News Preview
Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today reported financial results for the fourth quarter ("Q4'25") and year ended D...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
VKTX
LISTED
NASDAQ
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2025 on February 11, 2026
News Preview
Conference Call Scheduled for Wednesday, February 11 at 4:30 p.m. Eastern Time SAN DIEGO, Feb. 4, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will release fin...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
ARAY
LISTED
NASDAQ
Accuray Reports Fiscal 2026 Second Quarter Financial Results
News Preview
MADISON, Wis., Feb. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the second quarter ended December 31, 2025.
Key Highlights On December 15, 2025 the Company announced the first phase...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
SVRA
LISTED
NASDAQ
Savara Announces Participation in Upcoming Investor Healthcare Conferences
News Preview
Savara Inc. (Nasdaq: SVRA) (the “Company”), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will host one-on-one meetings and participate in fireside chats at two upcoming investor healthcare conferences.
Fireside Chats:
Guggenheim Emerging Outlook: Biotech Su...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
ACAD
LISTED
NASDAQ
Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026
News Preview
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on February 25, 2026, at 4:30 p.m. Eastern Time.
The conference ca...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
PLSE
LISTED
NASDAQ
Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026
News Preview
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced it will report business updates and financial results for the fourth quarter and full year 2025 after market close on Thursday, February 19, 2026.
Com...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
QGEN
LISTED
NYSE
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
News Preview
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the fourth quarter and full-year 2025.
Net sales for Q4 2025 rose 4% to $540 million, with sales at constant exchange rates (CER) up 1% and exceeding the outlook for steady CER results compared to the year-ago period while overcoming macroeconomic challenges and...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
STOK
LISTED
NASDAQ
Stoke Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. Today, the Company announced that Chie...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
NGNE
LISTED
NASDAQ
Neurogene Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 2,820 shares of t...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
TPST
LISTED
NASDAQ
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
News Preview
BRISBANE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company with a pipeline of advanced strategic therapeutic assets, today announced the closing of a previously announced transaction pursuant to which Tempest acquired certain dual-targeting chimeric antigen rec...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
PMI
LISTED
XASE
PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit With the Schall Law Firm
News Preview
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Picard Medical, Inc. (“Picard” or “the Company”) (NYSE American: PMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
STE
LISTED
NYSE
STERIS Announces Financial Results for Fiscal 2026 Third Quarter
News Preview
DUBLIN, IRELAND, Feb. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 third quarter ended December 31, 2025. Total revenue from continuing operations for the third quarter of fiscal 2026 increased 9% to $1.5 billion compared with $1.4 billion in the third quart...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
OLMA
LISTED
NASDAQ
Olema Oncology to Participate in Upcoming Investor Conferences
News Preview
Olema Oncology to Participate in Upcoming Investor Conferences...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
ENSG
LISTED
NASDAQ
The Ensign Group Reports Fiscal Year and Fourth Quarter 2025 Results; Issues 2026 Annual Earnings and Revenue Guidance
News Preview
Conference Call and Webcast scheduled for tomorrow, February 5, 2026 at 10:00 am PT Conference Call and Webcast scheduled for tomorrow, February 5, 2026 at 10:00 am PT...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
CORT
LISTED
NASDAQ
Securities Fraud Investigation Into Corcept Therapeutics Incorporated (CORT) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
TLRY
LISTED
TSX
CC Pharma, filiale de Tilray, figure parmi le classement TOP 100 Innovator en Allemagne
News Preview
Cette distinction récompense CC Pharma dans son rôle de leader de l’innovation et de partenaire de référence du marché pharmaceutique européen Cette distinction récompense CC Pharma dans son rôle de leader de l’innovation et de partenaire de référence du marché pharmaceutique européen...
Themefolio
Profiler
Peergroup
© Newsfile
04.02.2026
LOAN
LISTED
CSE
CSE Bulletin: Suspensions - LOAN, OIL
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 4 février/February 2026) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading Rules. Cease Trade Orders have been issued by one or more securities commissions....
Themefolio
Profiler
Peergroup
© Newsfile
04.02.2026
OSTX
LISTED
XASE
OS Therapies Applauds Reauthorization of Pediatric Priority Review Voucher Program to Advance Breakthrough Osteosarcoma Immunotherapies
News Preview
New York, New York--(Newsfile Corp. - February 4, 2026) - OS Therapies Inc. (NYSE American: OSTX) ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, is honored to celebrate the passage of the Mikaela Naylon Give Kids A Chance Act. Mikaela, like so many other children, courageously battled pediatric cancer...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Transaction in Own Shares
News Preview
For immediate release
04 February 2026
WORLDWIDE HEALTHCARE TRUST PLC
(the "Company")
MARKET PURCHA...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
04.02.2026
ONCO
LISTED
NEO
Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
News Preview
VANCOUVER, BC / ACCESS Newswire / February 4, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") announces that it has filed a preliminary base shelf prospectus dated February 3, 2026 (the "Base Shelf Prospectus") with the securities regulatory authorities i...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
CHEMM
LISTED
CPH
ChemoMetec enters Letter of Intent with Roche Diagnostics
News Preview
ANNOUNCEMENT NO. 300...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
CHEMM
LISTED
CPH
Interim report 2025/26 - Organic growth despite challenges in the North American market
News Preview
ANNOUNCEMENT NO. 299...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
EVH
LISTED
NYSE
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026
News Preview
WASHINGTON, Feb. 4, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its 2025 fourth quarter and year-end financial results on Tuesday, February 24, 2026, after market close, with a conference call to follow at 5 p.m. ET....
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
ALSAF
LISTED
EURONEXT
SAFE - Croissance de 6,5 % du chiffre d’affaires 2025 - Confirmation de la feuille de route
News Preview
Croissance de 6,5 % du chiffre d’affaires 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
CYH
LISTED
NYSE
Community Health Systems to Webcast Fourth Quarter and Year-End 2025 Conference Call
News Preview
Community Health Systems, Inc. (NYSE: CYH) today announced that it will webcast its fourth quarter and year-end 2025 conference call.
The Company will issue a press release announcing its results on Wednesday February 18, 2026, after the regular close of trading. The conference call is scheduled to begin at 10:00 a.m. Central Time, 11:00 a.m. Ea...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
TNG
LISTED
EURONEXT
Transgene Announces Financial Calendar for 2026
News Preview
Transgene Announces Financial Calendar for 2026...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
ACHC
LISTED
NASDAQ
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2025 Earnings Release
News Preview
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2025 results on Wednesday, February 25, 2026, before the market opens. Acadia will also conduct a conference call with institutional investors and analysts on Wednesday, February 25, 2026 at 9:00 a.m. ET. A live broadcast of the conf...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
ERF
LISTED
EURONEXT
Eurofins Scientific: Director/PDMR Shareholding
News Preview
Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.
This notification is made in accordance with the European Market Abuse Regulation.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
MDXG
LISTED
NASDAQ
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products
News Preview
Agreement expands offering to include additional sheet, particulate and flowable products Agreement expands offering to include additional sheet, particulate and flowable products...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
WAY
LISTED
NASDAQ
Waystar Earns Continued Best in KLAS Honors
News Preview
Recognition for Patient Access reflects strong client satisfaction with Waystar's industry-leading AI-powered platform LEHI, Utah and LOUISVILLE, Ky., Feb. 4, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced it has been named Best in KLAS® for Patient Access — extending its streak of co...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
IKS
LISTED
BSE
IKS Health Wins a 2026 Best in KLAS Award for Virtual Scribing Services for Second Year
News Preview
IKS Health, a global leader in care enablement solutions supporting clinicians, staff, and patients at every step of the care journey, is proud to announce it has been recognized by KLAS Research as a 2026 Best in KLAS provider for Virtual Scribe Services, receiving a 91.9 score out of 100 and earning As in four of the five customer experience are...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
SECT_B
LISTED
STO
Sectra continues to have the world's happiest customers--wins Best in KLAS Awards in North America, Europe, Middle East/Africa, and Oceania
News Preview
LINKÖPING, Sweden, Feb. 4, 2026 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has received seven Best in KLAS awards for its enterprise imaging solution (Sectra PACS). This top spot has been held for 13 consecutive years in the US and seven in Canada. Additionally, Sectra winners include Global PAC...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
CPIX
LISTED
NASDAQ
Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program
News Preview
NASHVILLE, Tenn., Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on developing new products for rare diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its novel oral therapy targeting a fatal form of heart diseas...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
DCOY
LISTED
NASDAQ
Decoy Therapeutics Participates in Virtual Investor "What This Means" Segment Highlighting Recently Announced Global Access Commitment Agreement
News Preview
Access the "What This Means" segment hereCAMBRIDGE, Mass. and HOUSTON, Feb. 4, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, today announced that it participated in a Virtual Investor "What This Means"...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
000220
LISTED
KOE
Yuyu Pharma Invests in James & Ella, Advancing Its Global Expansion Into Premium Pet Wellness
News Preview
SEOUL, South Korea, Feb. 4, 2026 /PRNewswire/ -- Yuyu Pharma announced today a strategic investment in James & Ella, the United Kingdom's fastest-growing freeze-dried pet nutrition company. Founded by entrepreneur James Middleton, James & Ella has rapidly established itself as the leader of the UK freeze-dried category, with nationwide dis...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
CRW
LISTED
AIMX
The Craneware Group Named 2026 Best in KLAS® for Trisus® Chargemaster
News Preview
Customer-validated recognition marks the company's 15th Best in KLAS award and underscores sustained platform execution.DEERFIELD BEACH, Fla., Feb. 4, 2026 /PRNewswire/ -- The Craneware Group, a leading innovator in healthcare technology, today announced that its Trisus® Chargemaster solution has been named 2026 Best in KLAS® for Revenue Cycle – C...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
TXG
LISTED
NASDAQ
PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology
News Preview
Initiative will create one of the world's largest multimodal cancer datasets and an integrated suite of AI models and tools to fuel precision medicinePLEASANTON, Calif., Feb. 4, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research consortium uniting four leadi...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
CODX
LISTED
OTC
Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification in Preparation for Manufacturing Upcoming PCR Platform
News Preview
Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new platformSALT LAKE CITY, Feb. 4, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
140410
LISTED
KOE
Mezzion Pharmaceuticals Applauds Give Kids a Chance Act Becoming Law
News Preview
FORT LEE, N.J., Feb. 4, 2026 /PRNewswire/ -- Mezzion Pharmaceuticals today welcomed the Mikaela Naylon Give Kids a Chance Act becoming law following President Trump's signing of H.R. 7148, the Consolidated Appropriations Act, 2026.
Th...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
HIMS
LISTED
NYSE
Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers to Cutting-Edge Proactive Care
News Preview
Today, Hims & Hers Health, Inc. (NYSE: HIMS), the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by Galleri®, a simple cancer screening blood test that can detect a signal for 50+ types of cancer even before symptoms appear1. This multi-cancer early detection (MCED) test combines Hims &am...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
ERF
LISTED
EURONEXT
Eurofins MET Laboratories Opens New Safety, EMC, Wireless, and Renewable Energy Laboratory in the Boston Tech Corridor
News Preview
Eurofins MET Laboratories, part of the Eurofins Electrical & Electronics global network, announces the opening of its new state-of-the-art 60,000-square-foot testing laboratory in Littleton, Massachusetts – a prime location in the Boston innovation corridor. Positioned at the epicenter of New England's med-tech, wireless innovation, clean ener...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
ACLX
LISTED
NASDAQ
Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel’s D-Domain Binder
News Preview
Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, announced today that a late-breaking abstract for its novel D-Domain binder in anitocabtagene autoleucel (anito-cel) has been accepted for presentation at the 2026 Tandem Meeti...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
NOVO B
LISTED
CPH
Novo Nordisk files annual report with the SEC
News Preview
Novo Nordisk A/S has filed its Annual Report 2025 on Form 20-F for the financial year 2025 with the US Securities and Exchange Commission...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
WWH
LISTED
LSE
Worldwide Healthcare Trust PLC - Net Asset Value(s)
News Preview
WORLDWIDE HEALTHCARE TRUST PLC
LEI: 5493003YBCY4W1IMJU04
NET ASSET VALUE
The estimated un-audited net asset val...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
VNRX
LISTED
XASE
Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation
News Preview
Showing New Indication for Nu.Q® NETs HENDERSON, Nev., Feb. 4, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, announces the sponsorship of a symposium at the European Hidradenitis Suppurativa Foundation (EHSF) Conference in Malta on 5th February.
The session entitled "Empowering...
Themefolio
Profiler
Peergroup
© BusinessWire
04.02.2026
HUM
LISTED
NYSE
Humana Report Finds Value-Based Care Improves Outcomes for Medicare Advantage Members
News Preview
Humana Inc. (NYSE: HUM), a health and well-being company focused on helping people live their healthiest lives, today released its latest Value-Based Care By the Numbers Report. The findings show that value-based care helps Medicare Advantage patients receive more personalized, preventive care while improving their overall health experience.
The...
Themefolio
Profiler
Peergroup
© PR Newswire
04.02.2026
HUM
LISTED
NYSE
Zynex Announces New In-Network Provider Status with Humana
News Preview
ENGLEWOOD, Colo., Feb. 4, 2026 /PRNewswire/ -- Zynex, Inc. (ZYXIQ), an innovative medical device company specializing in non-invasive medical devices for pain management, announced it has for the first time entered into a provider agreement with Humana Inc. (NYSE: HUM), effective February 1, 2026.
"Our non-invasive medical technology improves qual...
Themefolio
Profiler
Peergroup
© Globe Newswire
04.02.2026
ADIL
LISTED
NASDAQ
Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04
News Preview
GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today applauded the passage by Congress and signing into law by President Donald J...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
